Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

ARCTARCT
13 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ARCTURUS THERAPEUTICS HLDGS

JACOBS LEVY EQUITY MANAGEMENT, INC holds 647,511 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $4.4M as of 2026-Q2. The position was increased (+225.8% shares). ARCT represents 0.0% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$4.4M

Current Shares

647,511

Total Value Change

+$3.9M

Total Shares Change

+630,273

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
647,511
+225.8%
$4.4M0.0%$6.72
43
2026-Q1
Decreased
198,728
-32.2%
$1.5M0.0%$7.91
0
2025-Q4
Decreased
293,050
-4.1%
$1.8M0.0%$6.19
0
2025-Q3
Decreased
305,659
-38.3%
$5.6M0.0%$18.78
0
2025-Q2
Increased
495,291
+243.6%
$6.4M0.0%$13.33
44
2025-Q1
Increased
144,141
+20.6%
$1.5M0.0%$11.58
30
2024-Q4
Increased
119,558
+19.9%
$2M0.0%$16.58
31
2024-Q3
Decreased
99,699
-0.6%
$2.3M0.0%$22.03
0
2024-Q2
Increased
100,336
+4.6%
$2.4M0.0%$24.35
27
2024-Q1
Increased
95,924
+111.0%
$3.2M0.0%$33.77
43
2023-Q4
Increased
45,454
+387.4%
$1.4M0.0%$31.53
41
2023-Q3
Decreased
9,326
-45.9%
$238,2790.0%$25.55
0
2023-Q2
New
17,238
-
$494,3860.0%$26.58
33

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used